Jubilant Pharmova Invests CAD 94.5M to Double Radiopharma Capacity

Jubilant Pharmova's Radiopharma business announced a significant investment of CAD 94.5 million to double the production capacity of its flagship product, RUBY-FILL®. This expansion, aimed at modernizing and expanding its Kirkland, Québec facility, will address the strong and growing demand for RUBY-FILL®, which has seen its customer base double in the last three years. The Government of Canada will support this initiative with CAD 23.8 million through the Strategic Response Fund. The investment will enhance Jubilant Radiopharma's capabilities in nuclear medicine, ensuring a reliable supply of essential radiopharmaceutical products globally. The company's Radiopharma division is a key player in diagnostic and therapeutic solutions, with a significant presence in the US through its radiopharmacy network.